Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Subjects:

Initial participants by wave*. by Yeo Ju Sohn (18536198)

Subjects:

General characteristics of research participants. by Yeo Ju Sohn (18536198)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. by Jizhao Li (5856650)

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

Supplementary data file of graphs. by Maha Rehman (17114332)

Subjects:

Tourism determinants’ marginal effects. by Sakar Hasan Hamza (20978818)

Subjects:

Descriptive statistics from 2005 to 2018. by Sakar Hasan Hamza (20978818)

Subjects:

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

Subjects:

Hausman test results. by Sakar Hasan Hamza (20978818)

Subjects:

Variable’s construction. by Sakar Hasan Hamza (20978818)

Subjects:

Raw dataset. by Sakar Hasan Hamza (20978818)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Measures. by Esther Kim (2996622)

Subjects: